Needham Gives a Buy Rating to Green Thumb Industries (GTBIF)

In a report released today, Matt McGinley from Needham assigned a Buy rating to Green Thumb Industries (GTBIFResearch Report), with a price target of $47.25. The company’s shares closed last Tuesday at $31.00.

According to, McGinley is a 5-star analyst with an average return of 65.1% and a 62.1% success rate. McGinley covers the Basic Materials sector, focusing on stocks such as Trulieve Cannabis, Curaleaf Holdings, and Aurora Cannabis.

Green Thumb Industries has an analyst consensus of Strong Buy, with a price target consensus of $47.28.

See today’s analyst top recommended stocks >>

The company has a one-year high of $39.11 and a one-year low of $11.60. Currently, Green Thumb Industries has an average volume of 263.3K.

Based on the recent corporate insider activity of 116 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GTBIF in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 12 states and operates over 30 cannabis stores under the chains Rise and Essence. Green Thumb is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon’s, Dogwalkers, and Beboe.